Shandong Jincheng Kunlun Pharmaceutical

Shandong Jincheng Kunlun Pharmaceutical is a prominent subsidiary of the Jincheng Pharmaceutical Group, specializing in the development and industrial-scale production of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). The company is a leading global supplier of core intermediates for carbapenem and cephalosporin antibiotics, most notably 4-AA (4-acetoxy-3-hydroxyethyl-azetidin-2-one). Its manufacturing operations are centered in Zibo, Shandong, where it maintains advanced facilities dedicated to complex chemical synthesis. Jincheng Kunlun plays a vital role in the global pharmaceutical supply chain, providing high-quality chemical precursors for life-saving anti-infective and antiviral drugs. The company emphasizes rigorous quality control and adheres to international standards to serve a diverse client base of global pharmaceutical manufacturers.